lung cancer | |||||
新闻 | |||||
Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in ... ... Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th ...
| |||||
Global Lung Cancer Treatment Drugs Market 2019 Major Applications by Players – Roche ... The Latest Report by Market Deeper: Global Lung Cancer Treatment Drugs Industry 2019 Market Research Report furnishes key depth Resolution on ...
| |||||
ACASA marks Great American Smokeout Nov. 21 According to the ACS, 1 in 5 deaths in the United States are smoking related, and 87% of lung cancer deaths are attributed to smoking. Lung cancer ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment